Boswellia for Pelvic Lymphedema After Cervical Cancer Radiation
Pelvic lymphedema affects between 12% and 43% of patients after cervical cancer radiation therapy. This article examines the evidence for Boswellia serrata and anti-inflammatory support as adjuncts to standard lymphedema care.
